DK1214937T3 - Terfenadincarboxylat og behandling af hudirritation - Google Patents

Terfenadincarboxylat og behandling af hudirritation

Info

Publication number: DK1214937T3
Authority: DK; Denmark
Prior art keywords: treatment; skin irritation; compound; formula; terfenadine carboxylate
Prior art date: 1992-08-03

Application number

DK02006356T

Other languages

English (en)

Inventor

Nancy M Gray

Yiwang Chen

Raymond L Woosley

James W Young

Original Assignee

Sepracor Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-08-03

Filing date

1993-08-03

Publication date

2007-09-17

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27129882&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1214937(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1993-08-03 Application filed by Sepracor Inc filed Critical Sepracor Inc

2007-09-17 Application granted granted Critical

2007-09-17 Publication of DK1214937T3 publication Critical patent/DK1214937T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Pulmonology (AREA)
Immunology (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Hydrogenated Pyridines (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Epoxy Compounds (AREA)

DK02006356T 1992-08-03 1993-08-03 Terfenadincarboxylat og behandling af hudirritation DK1214937T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US92418292A	1992-08-03	1992-08-03
US92415692A	1992-08-03	1992-08-03
PCT/US1993/007260 WO1994003170A1 (en)	1992-08-03	1993-08-03	Terfenadine metabolites and their optically pure isomers for treating allergic disorders

Publications (1)

Publication Number	Publication Date
DK1214937T3 true DK1214937T3 (da)	2007-09-17

Family

ID=27129882

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
DK02006356T DK1214937T3 (da)	1992-08-03	1993-08-03	Terfenadincarboxylat og behandling af hudirritation
DK93918584T DK0701443T4 (da)	1992-08-03	1993-08-03	Terfenadinmetabolitter og deres optisk rene isomerer til behandling af allergiske lidelser
DK97104837T DK0815860T3 (da)	1992-08-03	1993-08-03	Terfenadincarboxylat og behandlingen af allergiske lidelser

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
DK93918584T DK0701443T4 (da)	1992-08-03	1993-08-03	Terfenadinmetabolitter og deres optisk rene isomerer til behandling af allergiske lidelser
DK97104837T DK0815860T3 (da)	1992-08-03	1993-08-03	Terfenadincarboxylat og behandlingen af allergiske lidelser

Country Status (24)

Country	Link
US (1)	US5375693A (da)
EP (4)	EP0815860B1 (da)
JP (6)	JP3041954B2 (da)
KR (1)	KR950702420A (da)
AT (3)	ATE363283T1 (da)
AU (3)	AU675240B2 (da)
BR (1)	BR9306841A (da)
CA (1)	CA2141572C (da)
CZ (1)	CZ27495A3 (da)
DE (5)	DE69316660T3 (da)
DK (3)	DK1214937T3 (da)
ES (3)	ES2257757T3 (da)
FI (1)	FI950467A (da)
GB (1)	GB2284351B (da)
GR (3)	GR960300024T1 (da)
HK (1)	HK1045806B (da)
HU (1)	HU226242B1 (da)
NO (1)	NO310644B1 (da)
PL (1)	PL174373B1 (da)
PT (2)	PT815860E (da)
RO (1)	RO116043B1 (da)
RU (1)	RU2167657C2 (da)
SK (1)	SK12495A3 (da)
WO (1)	WO1994003170A1 (da)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ251834A (en) *	1992-05-11	1997-07-27	Merrell Dow Pharma	Use of acid derivatives of terfenadine as antihistamines
DK1214937T3 (da)	1992-08-03	2007-09-17	Sepracor Inc	Terfenadincarboxylat og behandling af hudirritation
US20020007068A1 (en)	1999-07-16	2002-01-17	D'ambra Thomas E.	Piperidine derivatives and process for their production
ATE174589T1 (de) *	1993-06-24	1999-01-15	Albany Molecular Res Inc	Verfahren zur herstellung von piperidinderivaten
WO1995010278A1 (en) *	1993-10-15	1995-04-20	Hoechst Marion Roussel, Inc.	Treatment of allergic disorders with terfenadine carboxylate
US20030045722A1 (en) *	1994-05-18	2003-03-06	Henton Daniel R.	Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
EP1178041A1 (en)	1994-05-18	2002-02-06	Aventis Pharmaceuticals Inc.	Process for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives
US5455049A (en) *	1995-01-04	1995-10-03	Ascent Pharmaceuticals, Inc.	Terfenadine oral powder
MX9706449A (es) *	1995-02-28	1997-11-29	Hoechst Marion Roussel Inc	Composicion farmaceutica para compuestos de piperidinalcanol.
GB9513972D0 (en) *	1995-07-08	1995-09-06	Merck Sharp & Dohme	Pharmaceutical compositions
US5906747A (en) *	1995-11-13	1999-05-25	Biosepra Inc.	Separation of molecules from dilute solutions using composite chromatography media having high dynamic sorptive capacity at high flow rates
US6355656B1 (en)	1995-12-04	2002-03-12	Celgene Corporation	Phenidate drug formulations having diminished abuse potential
US5908850A (en) *	1995-12-04	1999-06-01	Celgene Corporation	Method of treating attention deficit disorders with d-threo methylphenidate
US6486177B2 (en) *	1995-12-04	2002-11-26	Celgene Corporation	Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
US5837284A (en) *	1995-12-04	1998-11-17	Mehta; Atul M.	Delivery of multiple doses of medications
US5922736A (en) *	1995-12-04	1999-07-13	Celegene Corporation	Chronic, bolus administration of D-threo methylphenidate
US5733756A (en) *	1996-01-05	1998-03-31	Celgene Corporation	Lactams and processes for stereoselective enrichment of lactams, amides, and esters
US6201124B1 (en)	1995-12-21	2001-03-13	Albany Molecular Research, Inc.	Process for production of piperidine derivatives
US6153754A (en)	1995-12-21	2000-11-28	Albany Molecular Research, Inc.	Process for production of piperidine derivatives
ES2124167B1 (es) *	1996-06-04	1999-09-16	Espanola Prod Quimicos	Nuevos derivados del bencimidazol con actividad antihistaminica.
US5925761A (en) *	1997-02-04	1999-07-20	Sepracor Inc.	Synthesis of terfenadine and derivatives
US6962997B1 (en) *	1997-05-22	2005-11-08	Celgene Corporation	Process and intermediates for resolving piperidyl acetamide steroisomers
ID22891A (id) *	1997-08-26	1999-12-16	Hoechst Marion Roussel Inc	Komposisi farmasi untuk kombinasi piperidinoalkanol-dekongestan
US6194431B1 (en) *	1998-04-14	2001-02-27	Paul D. Rubin	Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors
DE19913862C2 (de) *	1999-03-26	2003-04-10	Forschungszentrum Juelich Gmbh	Verfahren zur biokatalysierten Umsetzung schlecht wasserlöslicher Substanzen
DE10007203A1 (de) *	2000-02-17	2001-08-23	Asta Medica Ag	Neue Kombination nichtsedierender Antihistaminika mit Substanzen, die die Leukotrienwirkung beeinflussen, zur Behandlung der Rhinitis/Konjunktivitis
US6613907B2 (en)	2000-11-08	2003-09-02	Amr Technology, Inc.	Process for the production of piperidine derivatives with microorganisms
WO2002080857A2 (en) *	2001-04-09	2002-10-17	Teva Pharmaceutical Industries Ltd.	Polymorphs of fexofenadine hydrochloride
US20030021849A1 (en) *	2001-04-09	2003-01-30	Ben-Zion Dolitzky	Polymorphs of fexofenadine hydrochloride
WO2003020274A1 (en) *	2001-08-30	2003-03-13	Aventis Pharmaceuticals Inc.	Treatment of atopic dermatitis
EP1474392A1 (en) *	2002-06-10	2004-11-10	Teva Pharmaceutical Industries Ltd.	Polymorphic form xvi of fexofenadine hydrochloride
US20050026890A1 (en) *	2003-07-31	2005-02-03	Robinson Cynthia B.	Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease
TW200517114A (en)	2003-10-15	2005-06-01	Combinatorx Inc	Methods and reagents for the treatment of immunoinflammatory disorders
JP4515121B2 (ja)	2004-03-15	2010-07-28	東芝テック株式会社	ワイヤドットプリンタヘッド及びワイヤドットプリンタ
JP4473021B2 (ja)	2004-03-22	2010-06-02	東芝テック株式会社	窒化層形成方法、磁気回路形成部材、アーマチュア、ワイヤドットプリンタヘッド及びワイヤドットプリンタ
US20050239830A1 (en) *	2004-04-26	2005-10-27	Vikram Khetani	Methods of diminishing co-abuse potential
KR20070007196A (ko) *	2004-04-26	2007-01-12	테바 파마슈티컬 인더스트리즈 리미티드	펙소페나딘 히드로클로라이드의 결정형 및 이의 제조 방법
US7498443B2 (en)	2004-09-17	2009-03-03	Albany Molecular Research, Inc.	Process for production of carebastine
US7498345B2 (en)	2004-09-17	2009-03-03	Albany Molecular Research, Inc.	Process for production of piperidine derivatives
US20060148851A1 (en) *	2004-09-28	2006-07-06	Shlomit Wizel	Fexofenadine crystal form and processes for its preparation thereof
US20060127421A1 (en) *	2004-12-09	2006-06-15	Celgene Corporation	Treatment using D-threo methylphenidate
US8067433B2 (en)	2005-11-09	2011-11-29	Zalicus Inc.	Methods, compositions, and kits for the treatment of ophthalmic disorders
EA200970948A1 (ru) *	2007-04-13	2010-08-30	Саузерн Рисерч Инститьют	Антиангиогенные агенты и способы их применения
US20090076080A1 (en) *	2007-09-19	2009-03-19	Protia, Llc	Deuterium-enriched fexofenadine
WO2014052836A2 (en) *	2012-09-27	2014-04-03	Dunman Paul M	Methods and compositions for treating infection
WO2016154028A1 (en) *	2015-03-26	2016-09-29	Iversen Jacqueline M	Methods and compositions to inhibit symptoms associated with veisalgia
DE102017130361A1 (de)	2017-12-18	2019-07-04	Lsp Innovative Automotive Systems Gmbh	Statorzahn und Stator mit guter elektrischer Isolierung und gleichzeitig sehr hoher Wärmeleitfähigkeit zur Leistungssteigerung von Elektromotoren

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US880801A (en) †		1908-03-03	Harold Larsen	Vibrator.
US922890A (en) †	1907-03-26	1909-05-25	Peder Joergen Hansen	Stream-motor.
US4254129A (en) †	1979-04-10	1981-03-03	Richardson-Merrell Inc.	Piperidine derivatives
US4552899A (en) †	1984-04-09	1985-11-12	Analgesic Associates	Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4829064A (en) †	1987-06-08	1989-05-09	Analgesic Associates	Cough/cold mixtures comprising non-sedating antihistamine drugs
US4996061A (en) †	1987-10-07	1991-02-26	Merrell Dow Pharmaceuticals Inc.	Pharmaceutical composition for piperidinoalkanol-decongestant combination
US4929605A (en) *	1987-10-07	1990-05-29	Merrell Dow Pharmaceuticals Inc.	Pharmaceutical composition for piperidinoalkanol derivatives
CA2117892C (en) *	1992-04-10	2001-12-18	Chi-Hsin R. King	4-diphenylmethyl piperidine derivatives and process for their preparation
NZ251834A (en)	1992-05-11	1997-07-27	Merrell Dow Pharma	Use of acid derivatives of terfenadine as antihistamines
DK1214937T3 (da)	1992-08-03	2007-09-17	Sepracor Inc	Terfenadincarboxylat og behandling af hudirritation
ATE174589T1 (de) *	1993-06-24	1999-01-15	Albany Molecular Res Inc	Verfahren zur herstellung von piperidinderivaten
HU226037B1 (en) *	1993-06-25	2008-03-28	Aventis Inc	Process for producing antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives and novel intermediates
CA2128820A1 (en) *	1993-07-27	1995-01-28	Walter G. Gowan, Jr.	Rapidly disintegrating pharmaceutical dosage form and process for preparation thereof
CA2128821A1 (en) *	1993-07-27	1995-01-28	Dilip J. Gole	Freeze-dried pharmaceutical dosage form and process for separation thereof
WO1995010278A1 (en) *	1993-10-15	1995-04-20	Hoechst Marion Roussel, Inc.	Treatment of allergic disorders with terfenadine carboxylate

1993
- 1993-08-03 DK DK02006356T patent/DK1214937T3/da active
- 1993-08-03 KR KR1019950700382A patent/KR950702420A/ko not_active Application Discontinuation
- 1993-08-03 EP EP97104837A patent/EP0815860B1/en not_active Revoked
- 1993-08-03 AT AT02006356T patent/ATE363283T1/de active
- 1993-08-03 ES ES97104837T patent/ES2257757T3/es not_active Expired - Lifetime
- 1993-08-03 DE DE69316660T patent/DE69316660T3/de not_active Expired - Lifetime
- 1993-08-03 EP EP06114048A patent/EP1688142A1/en not_active Withdrawn
- 1993-08-03 SK SK124-95A patent/SK12495A3/sk unknown
- 1993-08-03 WO PCT/US1993/007260 patent/WO1994003170A1/en active IP Right Grant
- 1993-08-03 RU RU95107881/14A patent/RU2167657C2/ru active
- 1993-08-03 JP JP6505499A patent/JP3041954B2/ja not_active Expired - Lifetime
- 1993-08-03 AT AT93918584T patent/ATE162399T1/de active
- 1993-08-03 PT PT97104837T patent/PT815860E/pt unknown
- 1993-08-03 HU HU9500313A patent/HU226242B1/hu unknown
- 1993-08-03 RO RO95-00160A patent/RO116043B1/ro unknown
- 1993-08-03 DK DK93918584T patent/DK0701443T4/da active
- 1993-08-03 DE DE9320925U patent/DE9320925U1/de not_active Expired - Lifetime
- 1993-08-03 DE DE0701443T patent/DE701443T1/de active Pending
- 1993-08-03 BR BR9306841A patent/BR9306841A/pt not_active Application Discontinuation
- 1993-08-03 PL PL93307339A patent/PL174373B1/pl unknown
- 1993-08-03 AT AT97104837T patent/ATE322899T1/de active
- 1993-08-03 EP EP93918584A patent/EP0701443B2/en not_active Expired - Lifetime
- 1993-08-03 ES ES02006356T patent/ES2284740T3/es not_active Expired - Lifetime
- 1993-08-03 DE DE69334008T patent/DE69334008T2/de not_active Expired - Lifetime
- 1993-08-03 AU AU47986/93A patent/AU675240B2/en not_active Expired
- 1993-08-03 DK DK97104837T patent/DK0815860T3/da active
- 1993-08-03 PT PT02006356T patent/PT1214937E/pt unknown
- 1993-08-03 ES ES93918584T patent/ES2086270T5/es not_active Expired - Lifetime
- 1993-08-03 CA CA002141572A patent/CA2141572C/en not_active Expired - Lifetime
- 1993-08-03 DE DE69334145T patent/DE69334145T2/de not_active Expired - Lifetime
- 1993-08-03 EP EP02006356A patent/EP1214937B1/en not_active Revoked
- 1993-08-03 GB GB9502183A patent/GB2284351B/en not_active Revoked
1994
- 1994-02-02 US US08/191,061 patent/US5375693A/en not_active Expired - Lifetime
1995
- 1995-02-01 NO NO19950374A patent/NO310644B1/no not_active IP Right Cessation
- 1995-02-02 FI FI950467A patent/FI950467A/fi unknown
- 1995-02-03 CZ CZ95274A patent/CZ27495A3/cs unknown
1996
- 1996-05-31 GR GR960300024T patent/GR960300024T1/el unknown
- 1996-11-19 AU AU71822/96A patent/AU7182296A/en not_active Abandoned
1998
- 1998-04-03 GR GR980400714T patent/GR3026530T3/el unknown
1999
- 1999-02-25 AU AU18429/99A patent/AU1842999A/en not_active Abandoned
- 1999-10-13 JP JP11291216A patent/JP2000086512A/ja active Pending
- 1999-10-13 JP JP29122899A patent/JP3288662B2/ja not_active Expired - Lifetime
- 1999-10-13 JP JP11291230A patent/JP3037697B2/ja not_active Expired - Lifetime
- 1999-10-13 JP JP29122099A patent/JP3288660B2/ja not_active Expired - Lifetime
- 1999-10-13 JP JP29122399A patent/JP3288661B2/ja not_active Expired - Lifetime
2001
- 2001-02-14 GR GR20010400247T patent/GR3035417T3/el unknown
2002
- 2002-08-17 HK HK02106014.7A patent/HK1045806B/zh not_active IP Right Cessation

Also Published As

Publication number	Publication date
HUT71889A (en)	1996-02-28
PT1214937E (pt)	2007-07-25
DE69334008T2 (de)	2006-10-19
PL174373B1 (pl)	1998-07-31
AU1842999A (en)	1999-04-29
ES2284740T3 (es)	2007-11-16
DE69316660T2 (de)	1998-05-07
BR9306841A (pt)	1998-12-08
EP0815860A3 (en)	1998-01-14
EP0701443B2 (en)	2000-11-22
DE69316660D1 (de)	1998-02-26
AU675240B2 (en)	1997-01-30
ATE322899T1 (de)	2006-04-15
EP0701443B1 (en)	1998-01-21
EP1688142A1 (en)	2006-08-09
JP2000086514A (ja)	2000-03-28
GR3035417T3 (en)	2001-05-31
JP2000086515A (ja)	2000-03-28
AU4798693A (en)	1994-03-03
SK12495A3 (en)	1997-01-08
HK1045806B (zh)	2008-03-14
CA2141572A1 (en)	1994-02-17
ES2086270T3 (es)	1998-03-01
ES2257757T3 (es)	2006-08-01
GB9502183D0 (en)	1995-03-22
CZ27495A3 (en)	1996-09-11
NO950374D0 (no)	1995-02-01
DE9320925U1 (de)	1995-08-31
JP2000086512A (ja)	2000-03-28
DE69316660T3 (de)	2001-04-05
JPH08500348A (ja)	1996-01-16
EP1214937A2 (en)	2002-06-19
PL307339A1 (en)	1995-05-15
JP3041954B2 (ja)	2000-05-15
FI950467A (fi)	1995-03-31
GR3026530T3 (en)	1998-07-31
ATE363283T1 (de)	2007-06-15
NO950374L (no)	1995-03-29
JP2000086513A (ja)	2000-03-28
EP1214937B1 (en)	2007-05-30
HK1045806A1 (en)	2002-12-13
ATE162399T1 (de)	1998-02-15
HU9500313D0 (en)	1995-03-28
RU95107881A (ru)	1996-11-27
EP1214937A3 (en)	2002-10-30
GB2284351A (en)	1995-06-07
RU2167657C2 (ru)	2001-05-27
JP2000086516A (ja)	2000-03-28
KR950702420A (ko)	1995-07-29
JP3037697B2 (ja)	2000-04-24
JP3288662B2 (ja)	2002-06-04
ES2086270T5 (es)	2001-02-01
GB2284351B (en)	1996-11-27
DE69334145T2 (de)	2008-01-24
HU226242B1 (en)	2008-07-28
ES2086270T1 (es)	1996-07-01
RO116043B1 (ro)	2000-10-30
AU7182296A (en)	1997-01-30
EP0701443A1 (en)	1996-03-20
US5375693A (en)	1994-12-27
DE701443T1 (de)	1997-01-30
EP0815860B1 (en)	2006-04-12
WO1994003170A1 (en)	1994-02-17
PT815860E (pt)	2006-08-31
DE69334008D1 (de)	2006-05-24
JP3288661B2 (ja)	2002-06-04
GR960300024T1 (en)	1996-05-31
DK0815860T3 (da)	2006-08-14
NO310644B1 (no)	2001-08-06
CA2141572C (en)	2001-02-06
DE69334145D1 (de)	2007-07-12
DK0701443T3 (da)	1998-02-09
FI950467A0 (fi)	1995-02-02
DK0701443T4 (da)	2000-12-18
JP3288660B2 (ja)	2002-06-04
EP0815860A2 (en)	1998-01-07

Publication	Publication Date	Title
DK1214937T3 (da)	2007-09-17	Terfenadincarboxylat og behandling af hudirritation
DE69327328D1 (de)	2000-01-20	Verwendund von norastemizol zur behandlung der allergischen rhinitis
FR2613617B1 (fr)	1991-09-06	Agents medicamenteux pour la prevention et la therapie des brulures cutanees par rayons, contenant comme principe actif la 2,6-dimethyl-3,5-diethoxycarbonyl-1,4-dihydropyridine
ES2182840T3 (es)	2003-03-16	Factor xiii para el tratamiento de heridas de la piel.
RU94020964A (ru)	1996-03-27	Электростатический пластырь "элпласт"
CA2159609A1 (en)	1994-10-13	Factor xiii for treatment of skin wounds